Natural products as leads for tuberculosis drug development

Curr Top Med Chem. 2012;12(7):735-65. doi: 10.2174/156802612799984526.

Abstract

New therapeutics are urgently needed to combat the immense disease burden of tuberculosis and related mycobacterial diseases worldwide. Natural products continue to provide leads for the development of novel drugs to treat the rapidly growing numbers of patients with multi- and extensively-drug resistant tuberculosis. This review presents natural products and synthesized analogues with anti-mycobacterial activity published between 2006 through 2009. Structure activity relationships, synthetic analogues and newly reported activities of known compounds reported during this period are also included.

Publication types

  • Review

MeSH terms

  • Animals
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / pharmacology*
  • Biological Products / chemistry
  • Biological Products / pharmacology*
  • Drug Discovery*
  • Humans
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / genetics
  • Structure-Activity Relationship

Substances

  • Antitubercular Agents
  • Biological Products